EMEA-000065-PIP01-07-M05
Key facts
| Invented name |
Sebivo
|
| Active substance |
telbivudine
|
| Therapeutic area |
Gastroentology-Hepatology
|
| Decision number |
P/0152/2017
|
| PIP number |
EMEA-000065-PIP01-07-M05
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of chronic hepatitis B
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Novartis Europharm Limited
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|